The phase I trial NCT02544880 recently completed, where Hiltonol and Mucin1 were combined to make the MUC1 vaccine; together with influenza vaccine and PDE5 inhibitor Tadalafil, MUC1 vaccine has been used to treat solid tumors. The gene discussed is MUC1; the disease is influenza.